Liquid Tresiba Flextouch Insulin Pen 100 Ui/ml 5x3ml

Tresiba Flextouch from the Novo Nordisk manufacturer is a diabetes medicine with insulin degludec (one of the most long-acting basal type basal insulin) active substance to control blood glucose levels. The composition of the drug also includes glycerol a 19.6 mg, phenol a 1.5 mg, metacresol a 1.72 mg, zinc a 32.7 I g (in the form of zinc acetate a 109.7 I g), hydrochloric acid/sodium hydroxide (for pH correction), water a up to 1 ml.

The concentration of Tresiba Insulin Degludec is 100 units/ml of the solution.

The Tresiba remedy is an injectable liquid solution, which should be transparent and colorless. Do not use the drug if its consistency or color differs from the description or if it contains any particles in it.

The drug is available in two forms of release a vial for injections with a syringe and disposable pen.

You can buy Tresiba Flextouch on Insulin store. Please note that you must provide a valid prescription to place an order.

Indications
Diabetes mellitus in adults.

Dosage and Rules of Administration
The method of application and dosage regimen of Tresiba is individual and many factors. The optimal dose should be determined by your health care provider after a careful medical examination. It is necessary to strictly observe the compliance of the used dosage form of Tresiba drug with indications for use and dosage regimen.

Tresiba should be injected subcutaneously 1 time per day at any time of the day, but preferably at the same time every day.

Side Effects
From the immune system: rarely a hypersensitivity, urticaria.

From the side of metabolism and nutrition: very often a hypoglycemia.

On the part of the skin and subcutaneous tissues: infrequently a lipodystrophy.

General side effects: infrequently a peripheral edema, minor allergic reactions.

Local irritations: often a pain, local hemorrhage, erythema, connective tissue nodules, swelling, discoloration of the skin, itching, irritation, and induration at the injection site. Most reactions at the injection site are minor and temporary and usually disappear with continued treatment.

Contraindications
Children under the age of 18;
diabetic ketoacidosis;
pregnancy;
lactation (breastfeeding);
hypersensitivity to the active substance.
Never use Tresiba if you have any of the points described above.

Precautions: tell your doctor if you are pregnant or plan on pregnancy, change your diet, physical activity, or lifestyle as these may be serious reasons for canceling the intake of the medication or changing the dosage.

Application during pregnancy and lactation
Use during pregnancy is contraindicated. Use during breastfeeding is contraindicated because there is no clinical experience in lactating women.

Application in children
The drug is contraindicated for use in children and adolescents under the age of 18 years.